GMI
PFE icon

Greystone Managed Investments’s Pfizer PFE Stock Holding History

Greystone Managed Investments’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$12.5M Buy
367,638
+52,331
+17% +$1.9M 0.76% 38
2019
Q2 		$13M Sell
315,307
-6,767
-2% -$269K 0.74% 39
2019
Q1 		$13M Sell
322,074
-12,712
-4% -$509K 0.77% 40
2018
Q4 		$13.9M Sell
334,786
-5,807
-2% -$241K 0.88% 33
2018
Q3 		$14.2M Sell
340,593
-46,516
-12% -$1.79M 0.77% 41
2018
Q2 		$13.3M Buy
387,109
+5,529
+1% +$189K 0.58% 42
2018
Q1 		$12.8M Buy
381,580
+36,897
+11% +$1.27M 0.55% 36
2017
Q4 		$11.8M Buy
344,683
+2,662
+0.8% +$90.8K 0.49% 44
2017
Q3 		$11.6M Buy
342,021
+71,383
+26% +$2.29M 0.51% 41
2017
Q2 		$8.63M Sell
270,638
-5,249
-2% -$166K 0.4% 57
2017
Q1 		$8.96M Sell
275,887
-17,803
-6% -$561K 0.41% 55
2016
Q4 		$9.05M Sell
293,690
-15,791
-5% -$482K 0.4% 52
2016
Q3 		$9.95M Buy
309,481
+636
+0.2% +$21.3K 0.45% 45
2016
Q2 		$10.3M Sell
308,845
-57,489
-16% -$1.83M 0.42% 39
2016
Q1 		$10.3M Sell
366,334
-2,236
-0.6% -$63.9K 0.39% 41
2015
Q4 		$11.3M Sell
368,570
-24,885
-6% -$783K 0.43% 38
2015
Q3 		$11.7M Sell
393,455
-290,267
-42% -$9.31M 0.43% 35
2015
Q2 		$21.8M Sell
683,722
-271,026
-28% -$8.83M 0.57% 31
2015
Q1 		$31.5M Sell
954,748
-53,290
-5% -$1.69M 0.71% 32
2014
Q4 		$29.8M Sell
1,008,038
-48,033
-5% -$1.38M 0.63% 39
2014
Q3 		$29.6M Sell
1,056,071
-187,937
-15% -$5.27M 0.59% 38
2014
Q2 		$35M Buy
1,244,008
+70,998
+6% +$2.02M 0.64% 34
2014
Q1 		$35.7M Sell
1,173,010
-20,543
-2% -$613K 0.65% 32
2013
Q4 		$34.7M Sell
1,193,553
-223,457
-16% -$6.5M 0.57% 35
2013
Q3 		$38.6M Buy
1,417,010
+161,072
+13% +$4.38M 0.55% 29
2013
Q2 		$33.4M Buy
+1,255,938
New +$34.7M 0.5% 33

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Greystone Managed Investments's PFE Position: Q3 2019 in Review

Greystone Managed Investments increased its Pfizer (PFE) stake by 17% in Q3 2019, buying an estimated $1.9M and bringing the position to 367,638 shares worth $12.5M. The position accounts for 0.76% of the portfolio, ranked #38.

Greystone Managed Investments first reported a position in PFE in Q2 2013 and has held it in 26 quarters since. The position peaked at $38.6M in Q3 2013. 2,323 funds tracked by Wall St. Rank hold PFE as of Q3 2019.

  • Greystone Managed Investments held 367,638 shares of Pfizer worth $12.5M as of Q3 2019.
  • Greystone Managed Investments bought 52,331 Pfizer shares in Q3 2019, an estimated $1.9M.
  • Pfizer made up 0.76% of Greystone Managed Investments's portfolio in Q3 2019, its #38 holding.
  • Greystone Managed Investments first reported a position in Pfizer in Q2 2013 and has held it in 26 quarters since.
  • Greystone Managed Investments's Pfizer position peaked at $38.6M in Q3 2013.
  • 2,323 funds tracked by Wall St. Rank held Pfizer as of Q3 2019.

Based on Greystone Managed Investments's 13F filing for Q3 2019, filed 5 Nov 2019.